Outlook Therapeutics
OTLK
OTLK
15 hedge funds and large institutions have $16M invested in Outlook Therapeutics in 2017 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.01% less ownership
Funds ownership: 0.17% → 0.16% (-0.01%)
13% less capital invested
Capital invested by funds: $18.2M → $16M (-$2.28M)
Holders
15
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$454K | |
| 2 | +$370K | |
| 3 | +$40K | |
| 4 |
LCM
Landscape Capital Management
Englewood,
New Jersey
|
+$35K |
| 5 |
Morgan Stanley
New York
|
+$17.1K |
Top Sellers
| 1 | -$788K | |
| 2 | -$525K | |
| 3 | -$390K | |
| 4 |
JG
Jefferies Group
New York
|
-$296K |
| 5 |
PA
Perceptive Advisors
New York
|
-$180K |